Table 2.
Clinical characteristics of 127 children or adolescence with COVID-19. Values are mean±SD (standard deviation) or medians (interquartile ranges) unless stated otherwise.
| Total | Mild | Moderate | Severe/Critical | |
|---|---|---|---|---|
| White blood cells (4–10 109 cells per L) | 6.61 (2.09) | 6.61 (1.88) | 6.77 (2.17) | 5.33 (2.57) |
| Neutrophil (2–7 109 cells per L) | 2.94 (1.98) | 3.36 (2.58) | 2.72 (1.25) | 1.89 (1.80) |
| Lymphocytes (1–4 109 cells per L) | 3.07 (1.52) | 2.70 (0.96) | 3.35 (1.82) | 3.37 (1.81) |
| Eosinophil (0.05–0.5 109 cells per L) | 0.24 (0.38) | 0.15 (0.16) | 0.03 (0.03) | 0.13 (0.17) |
| Platelet (100–300 109 cells per L) | 298.90 (95.87) | 283.96 (74.42) | 296.15 (96.12) | 314.14 (28.47) |
| C-reactive protein (<0.75 mg/L) | 1.42 (1.97) | 2.09 (2.75) | 0.75 (0.01) | 0.75 (0.01) |
| Procalcitonin (≤0.05 ng/ml) | 0.07 (0.12) | 0.07 (0.15) | 0.06 (0.05) | 0.26 (0.24) |
| Fibrinogen (2–4 g/L) | 2.17 (0.64) | 2.23 (0.65) | 2.15 (0.65) | 2.07 (0.28) |
| D-dimer (0–0.55 mg/L) | 0.44 (1.12) | 0.24 (0.31) | 0.67 (1.63) | 0.15 (0.04) |
| Alanine aminotransferase (21–27 IU/L) | 29.74 (58.59) | 24.96 (10.99) | 47.29 (85.83) | 19.57 (22.90) |
| Aspartate transferase (15–46 IU/L) | 36.38 (61.71) | 15.07 (8.43) | 44.50 (81.46) | 27.71 (6.63) |
| Creatinine (58–110umol/L) | 37.38 (14.02) | 41.68 (13.50) | 33.30 (13.68) | 37.5 (7.64) |
| Blood urea nitrogen (3.2–7.1 mmol/L) | 4.20 (1.52) | 4.41 (1.28) | 3.98 (1.68) | 4.75 (0.72) |
| Calcium (2.1–2.55 mmol/L) | 2.47 (0.12) | 2.46 (0.11) | 2.48 (0.13) | 2.45 (0.14) |
| Infiltration of lung | ||||
| Pneumonia No. | 68 | 0 | 63 | 5 |
| non-pneumonia No. | 59 | 57 | 0 | 2 |
| No. of lobes affected, median[IQR] | 1 [1–2] | 0 | 2 [1–2] | 1 [1–3.5] |
Data are mean (standard deviation), unless otherwise indicate. COVID-19, coronavirus disease 2019.